Results 101 to 110 of about 12,817 (217)

Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport.

open access: yesPLoS ONE, 2014
Nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) serves dual functions in viral RNA replication and virus assembly. Here, we demonstrate that HCV replication complex along with NS5A and Core protein was transported to the lipid droplet (LD ...
Chao-Kuen Lai   +5 more
doaj   +1 more source

Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response

open access: yesBMC Infectious Diseases, 2010
Background The quasispecies nature of HCV may have important implications for viral persistence, pathogenicity and resistance to antiviral agents. The variability of one of the viral proteins, NS5A, is believed to be related to the response to IFN ...
Rahal Paula   +7 more
doaj   +1 more source

NS5A stability of H77C(1a) mutants.

open access: yes, 2012
Amounts of NS5A were compared to Core after spread of infection to >80% of Huh7.5 cells transfected with H77C(1a) and P346A/P351A/P354A, Δ414-428 or “Δ414-428+20aa” mutants.
Thomas H. R. Carlsen (162324)   +5 more
core   +1 more source

Mapping of the PI4KIIIα - interaction site within NS5A domain 1.

open access: yes, 2013
A: Schematic representation of expression constructs with deletions in NS5A D1 used to identify the PI4KIIIα interaction site. HCV coding sequences are indicated by blue or grey boxes, deleted sequences by black lines.
Volker Lohmann (115772)   +8 more
core   +1 more source

Two different NS5A dimer-interface mutations impaired both gt1a H77 and gt2a JFH1 NS5A self-interactions.

open access: yes, 2018
(A) An NS5A self-interaction was determined by performing a checkmate mammalian two-hybrid assay in Huh-7 cells. Interaction between GAL4/BD (GAL4 DNA binding domain)-fused protein and VP16/AD (VP16 activation domain)-fused protein resulted in increased ...
Alyssa K. Nichols (5545664)   +4 more
core   +1 more source

Interfering with interferon: developing a reporter system to study the interaction between hepatitus C viral proteins and the interferon signalling pathway [PDF]

open access: yes, 2008
PhDThe aim of the project was to investigate the mechanism by which HCV evades therapeutic IFN treatment. This involved the development of novel testing systems and their application to patient samples.
Jones, Meleri
core   +1 more source

Hepatitis C virus nonstructural protein 5A perturbs lipid metabolism by modulating AMPK/SREBP-1c signaling

open access: yesLipids in Health and Disease, 2019
Background Steatosis is an important clinical manifestation associated with chronic hepatitis C virus (HCV) infection. AMP-activated protein kinase (AMPK), a major mediator of lipid metabolism, regulates HCV-associated hepatic steatosis, but the ...
Ziyu Meng   +3 more
doaj   +1 more source

NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase III∝ complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes

open access: yes, 2014
The hepatitis C virus (HCV) nonstructural (NS) protein 5A is a multifunctional protein that plays a central role in viral replication and assembly. Antiviral agents directly targeting NS5A are currently in clinical development.
P. Neddermann   +9 more
core   +1 more source

An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.

open access: yesPLoS ONE, 2017
The objective was to develop a method of HCV genome sequencing that allowed simultaneous genotyping and NS5A inhibitor resistance profiling. In order to validate the use of a unique RT-PCR for genotypes 1-5, 142 plasma samples from patients infected with
Elisabeth Andre-Garnier   +12 more
doaj   +1 more source

HCV core residues critical for infectivity are also involved in core-NS5A complex formation.

open access: yesPLoS ONE, 2014
Hepatitis C virus (HCV) infection is a major cause of liver disease. The molecular machinery of HCV assembly and particle release remains obscure. A better understanding of the assembly events might reveal new potential antiviral strategies.
Katarzyna Gawlik   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy